Skip to main content
. 2022 May 19;14(5):1088. doi: 10.3390/pharmaceutics14051088

Figure 7.

Figure 7

Cumulative drug release curves for BSA–polymer conjugates from (a) pCD MPs, (b) pCD MPs zoomed in on release days 9–65, and (c) pCD SRPL and (d) pCD SRPL zoomed in on release days 9–65. All datasets were found to be statistically significant from one another (one-way ANOVA with Tukey, p < 0.05), except BSA 4 and BSA 8 curves in both MP and SRPL trials.